TVARDI THERAPEUTICS, INC. Increase (Decrease) in Restricted Cash
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Restricted Cash of -$700.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-15
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-03-31 was $769.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2017 was -$700.00K, a 191.03% decline from fiscal 2016.
- TVARDI THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2016 was $769.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$700.00K 10-K · filed 2018-03-15 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $769.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $769.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $769.00K 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $769.00K 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |